South Korea’s Ildong Pharma To License Arena Pharma Drug

Arena Pharma has licensed its thrombosis drug to Seoul-based Ildong Pharma for further clinical testing and development in South Korea.

Boston Healthcare To Expand Consultancy Into Asia

Boston Healthcare is expanding into Asia with the formation of a strategic advisory practice in Hong Kong.

Simcere To Begin Clinical Trials On VEGF Inhibitor

Simcere Pharma has received SFDA approval to begin first-in-man trials with its humanized monoclonal antibody candidate, APX003.

Takeda Pharma To Acquire Envoy Therapeutics

Takeda’s subsidiary, Takeda America Holdings is set to acquire Envoy for up to US$140 million in cash.

Novartis To Build US$500m Biotech Facility In Singapore

Novartis announced today the construction of a new state-of-the-art biotechnology facility in Singapore with an investment valued at over US$500 million.

TauRx Therapeutics Initiates Two Phase III Trials For Alzheimer’s Drug

Singapore-based biotech company TauRx Therapeutics Ltd announced today the initiation of two global Phase III clinical trials for its Alzheimer’s disease drug.

Del Mar Pharma Announces Strategic Collaboration In China

Del Mar Pharma announced on Monday a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083, known in China as DAG for Injection.

Shanghai MengKe Pharma To Develop MRX-I Antibiotic For Chinese Market

MicuRx Pharma and Shanghai Zhangjiang Biomedical Industry Venture Capital today announced a joint venture to develop MRX-I for the Chinese market.

Ironwood, AstraZeneca To Develop Linaclotide In China

AstraZeneca and Ironwood Pharmaceuticals, Inc. announced this week an agreement to co‐develop and co‐commercialize Ironwood’s linaclotide in China.